Revisão
Current advances in targeted therapies for metastatic gastric cancer: improving patient care
Fecha
2016Registro en:
Future Oncology. London, v. 12, n. 6, p. 839-854, 2016.
1479-6694
10.2217/fon.15.348
WOS:000371064800012
Autor
Aguiar, Pedro Nazareth, Jr. [UNIFESP]
Muniz, Thiago Pimentel [UNIFESP]
Miranda, Raelson Rodrigues [UNIFESP]
Tadokoro, Hakaru [UNIFESP]
Forones, Nora Manoukian [UNIFESP]
Monteiro, Ines-de-Paula
Castelo-Branco, Pedro
Janjigian, Yelena Y.
de Mello, Ramon Andrade
Institución
Resumen
In this article, we review the literature on the current advances in targeted therapies for metastatic gastric cancer aimed at improving patient care. We conclude that the key to guiding targeted therapy is individual biomarkers, which are not completely elucidated. HER2 overexpression is the only predictive biomarker currently in use. Furthermore, it is necessary to understand that gastric tumors are heterogeneous therefore, is impossible to evaluate a novel biological compound without evaluating personal biomarkers. The selection of patients who are able to receive each treatment is paramount for improving advanced gastric cancer survival and reducing unnecessary costs.
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Measurement of Calcitonin and Calcitonin Gene-Related Peptide mRNA Refines the Management of Patients with Medullary Thyroid Cancer and May Replace Calcitonin-Stimulation Tests
Camacho, Cleber P. [UNIFESP]; Lindsey, Susan C. [UNIFESP]; Melo, Maria Clara C. [UNIFESP]; Yang, Ji H. [UNIFESP]; Germano-Neto, Fausto [UNIFESP]; Valente, Flavia de O. F. [UNIFESP]; Lima, Thiago R. N. [UNIFESP]; Biscolla, Rosa Paula M. [UNIFESP]; Vieira, Jose G. H. [UNIFESP]; Cerutti, Janete M. [UNIFESP]; Dias-da-Silva, Magnus R. [UNIFESP]; Maciel, Rui M. B. [UNIFESP] (Mary Ann Liebert Inc, 2013-03-01)Background: Serum calcitonin (sCT) is the main tumor marker for medullary thyroid cancer (MTC), but it has certain limitations. Various sCT assays may have important intra-assay or interassay variation and may yield different ... -
Identification of suitable reference genes for miRNA expression normalization in gastric cancer
Anauate, Ana Carolina [UNIFESP]; Leal, Mariana Ferreira [UNIFESP]; Wisnieski, Fernanda [UNIFESP]; Santos, Leonardo Caires [UNIFESP]; Gigek, Carolina Oliveira [UNIFESP]; Chen, Elizabeth Suchi [UNIFESP]; Geraldis, Jaqueline Cruz [UNIFESP; Calcagno, Danielle Queiroz; Assumpcao, Paulo Pimentel; Demachki, Samia; Arasaki, Carlos Haruo [UNIFESP]; Lourenco, Laercio Gomes [UNIFESP]; Artigiani, Ricardo [UNIFESP]; Burbano, Rommel Rodriguez; Cardoso Smith, Marilia Arruda [UNIFESP] (Elsevier Science Bv, 2017) -
Differential expression of histone deacetylase and acetyltransferase genes in gastric cancer and their modulation by trichostatin A
Wisnieski, Fernanda [UNIFESP]; Calcagno, Danielle Queiroz [UNIFESP]; Leal, Mariana Ferreira [UNIFESP]; Chen, Elizabeth Suchi [UNIFESP]; Gigek, Carolina Oliveira [UNIFESP]; Santos, Leonardo Caires [UNIFESP]; Pontes, Thais Brilhante [UNIFESP]; Rasmussen, Lucas Trevizani; Payão, Spencer Luiz Marques [UNIFESP]; Assumpcao, Paulo Pimentel; Lourenço, Laércio Gomes [UNIFESP]; Demachki, Samia; Artigiani, Ricardo [UNIFESP]; Burbano, Rommel Rodriguez; Smith, Marilia Cardoso [UNIFESP] (Springer, 2014-07-01)Gastric cancer is still the second leading cause of cancer-related death worldwide, even though its incidence and mortality have declined over the recent few decades. Epigenetic control using histone deacetylase inhibitors, ...